Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Camille L, Bedrosian"'
Autor:
Daruka Mahadevan, Mark C. Lanasa, Charles Farber, Manjari Pandey, Maria Whelden, Susan J. Faas, Terrie Ulery, Anjli Kukreja, Lan Li, Camille L. Bedrosian, Xiaoping Zhang, Leonard T. Heffner
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Abstract Purpose Samalizumab is a novel recombinant humanized monoclonal antibody that targets CD200, an immunoregulatory cell surface member of the immunoglobulin superfamily that dampens excessive immune responses and maintains self-tolerance. This
Externí odkaz:
https://doaj.org/article/7e580304b69a4cc98a69249f054eaef7
Autor:
Jerry, Vockley, Gregory M, Enns, Antonio Nino, Ramirez, Camille L, Bedrosian, Bridget, Reineking, Xiaoxiao, Lu, Kathryn, Ray, Syeda, Rahman, Deborah, Marsden
Publikováno v:
Molecular Genetics and Metabolism. 136:152-162
Long-chain fatty acid oxidation disorders (LC-FAOD) are a group of inborn errors of metabolism wherein patients are unable to process long-chain fatty acids into useable energy in the mitochondria. LC-FAOD commonly affects organ systems with high ene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ad41a5377c572b426effb71c1f91b6f
https://doi.org/10.1016/j.ymgme.2022.04.001
https://doi.org/10.1016/j.ymgme.2022.04.001
Autor:
Emil D. Kakkis, Ivailo Tournev, Camille L Bedrosian, Mark A. Tarnopolsky, Anthony Behin, Alison Skrinar, Hanns Lochmüller, Tahseen Mozaffar, Tony Koutsoukos, J. Shah, Oksana Pogoryelova, Rita Horvath
Publikováno v:
Journal of neuromuscular diseases, vol 8, iss 2
Journal of Neuromuscular Diseases
Journal of Neuromuscular Diseases, 2021, 8 (2), pp.225-234. ⟨10.3233/jnd-200565⟩
Journal of Neuromuscular Diseases, IOS Press, 2021, 8 (2), pp.225-234. ⟨10.3233/jnd-200565⟩
Journal of Neuromuscular Diseases
Journal of Neuromuscular Diseases, 2021, 8 (2), pp.225-234. ⟨10.3233/jnd-200565⟩
Journal of Neuromuscular Diseases, IOS Press, 2021, 8 (2), pp.225-234. ⟨10.3233/jnd-200565⟩
Author(s): Lochmuller, Hanns; Behin, Anthony; Tournev, Ivailo; Tarnopolsky, Mark; Horvath, Rita; Pogoryelova, Oksana; Shah, Jinay; Koutsoukos, Tony; Skrinar, Alison; Kakkis, Emil; Bedrosian, Camille L; Mozaffar, Tahseen | Abstract: BackgroundGNE myop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e879c36df374f48285e7a67cb79dc7c9
https://escholarship.org/uc/item/4rd9372s
https://escholarship.org/uc/item/4rd9372s
Autor:
Bridget Reineking, Antonio Nino Ramirez, Camille L. Bedrosian, Jerry Vockley, Gregory M. Enns, Deborah Marsden, Syeda Rahman, Xiaoxiao Lu
Publikováno v:
Molecular Genetics and Metabolism. 132:S86-S87
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59bc0bd3fe08e13a48fc2afc9dd9d4c0
https://doi.org/10.1016/s1096-7192(21)00215-8
https://doi.org/10.1016/s1096-7192(21)00215-8
Publikováno v:
Molecular Genetics and Metabolism. 132:S76-S77
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::13f015f8c3c147108e707cbf1d46db3e
https://doi.org/10.1016/s1096-7192(21)00197-9
https://doi.org/10.1016/s1096-7192(21)00197-9
Autor:
Kathryn Ray, Michelle Polowski, Camille L. Bedrosian, Kevin McMahon, Deborah Marsden, Jerry Vockley, Syeda Rahman, Antonio Nino Ramirez
Publikováno v:
Molecular Genetics and Metabolism. 132:S20-S21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dc9f98aef865e94e9b5125d35076dc98
https://doi.org/10.1016/s1096-7192(21)00116-5
https://doi.org/10.1016/s1096-7192(21)00116-5
Autor:
Camille L. Bedrosian, Xiaoping Zhang, Maria Whelden, Mark C. Lanasa, Lan Li, Charles M. Farber, Terrie L Ulery, Susan J. Faas, Manjari Pandey, Anjli Kukreja, Leonard T. Heffner, Daruka Mahadevan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
Purpose Samalizumab is a novel recombinant humanized monoclonal antibody that targets CD200, an immunoregulatory cell surface member of the immunoglobulin superfamily that dampens excessive immune responses and maintains self-tolerance. This first-in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b470ec25db3dee971cdc85765394090
https://doi.org/10.1186/s40425-019-0710-1
https://doi.org/10.1186/s40425-019-0710-1
Autor:
Alexander Cole, Marie-Pierre Caby-Tosi, Camille L. Bedrosian, Jing L. Marantz, Hermann Haller, Arshad Mujeebuddin, Peter Hillmen, Gérard Socié, Johan Vande Walle, Christoph Gasteyger
Publikováno v:
BRITISH JOURNAL OF HAEMATOLOGY
British Journal of Haematology
British Journal of Haematology
Eculizumab is the first and only medication approved for paroxysmal nocturnal haemoglobinuria (PNH) and atypical haemolytic uraemic syndrome (aHUS) treatment. However, eculizumab safety based on long-term pharmacovigilance is unknown. This analysis s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b36c823e18944f6af4b8c25021c13c6f
https://biblio.ugent.be/publication/8643652
https://biblio.ugent.be/publication/8643652
Publikováno v:
Molecular Genetics and Metabolism. 132:S69
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ed58cecccab58c3d5e34c7d8af81f91
https://doi.org/10.1016/j.ymgme.2020.12.158
https://doi.org/10.1016/j.ymgme.2020.12.158
Autor:
Camille L. Bedrosian
Publikováno v:
Journal of the Neurological Sciences. 411:116724
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7eb6b91812c08159e8552c79c0b440cd
https://doi.org/10.1016/j.jns.2020.116724
https://doi.org/10.1016/j.jns.2020.116724